Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis | Zendy

Matthew J. Klebanoff | Zendy; Kathleen E. Corey | Zendy; Sumeyye Samur | Zendy; Jin Choi | Zendy; Lee M. Kaplan | Zendy; Jagpreet Chhatwal | Zendy; Chin Hur | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis

Author(s) -

Matthew J. Klebanoff,

Kathleen E. Corey,

Sumeyye Samur,

Jin Choi,

Lee M. Kaplan,

Jagpreet Chhatwal,

Chin Hur

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.0047

Subject(s) - medicine , cirrhosis , overweight , sleeve gastrectomy , nonalcoholic fatty liver disease , perioperative , weight loss , population , surgery , obesity , fatty liver , disease , gastric bypass , environmental health

Key Points Question Is bariatric surgery cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis? Findings In this simulation model study, laparoscopic sleeve gastrectomy had an incremental cost-effectiveness ratio of $66 119 per quality-adjusted life-year in overweight patients, $18 716 per quality-adjusted life-year in patients with mild obesity, $10 274 per quality-adjusted life-year in patients with moderate obesity, and $6563 per quality-adjusted life-year in patients with severe obesity. Meaning Bariatric surgery could be highly cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis, even in those with a lower baseline body mass index.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research